A Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of BBM-D101 in the Treatment of Duchenne Muscular Dystrophy.
Clinical trial NCT07058662 · RECRUITING
Trial details
- NCT number
- NCT07058662
- Sponsor
- Belief BioMed (Beijing) Co., Ltd
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-31
- Primary completion
- 2027-06-30
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.